Glucose management impact of asken medical system in patients with type 2 diabetes.

Phase 2

• Conditions: Type 2 diabetes; D003924

• Registration Number: JPRN-jRCTs052220099
• Lead Sponsor: Kawashima Sachiko

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-09-27
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

1) Type 2 diabetes
2) Diabetic nephropathy stage 1 or 2
3) Aged 20 y.o. or older
4) HbA1c >= 7.0%
5) Mobile device user
6) Written informed consent

Exclusion Criteria

1) Using application assessing dietary intake
2) Pregnant or suspected to be pregnant
3) Breastfeeding
4) Less than 84 days after diagnosed with diabetes
5) Continuous administration of steroids
6) eGFR < 45ml/min/1.73cm2
7) Chronic pancreatitis or pancreatic cancer
8) Liver cirrhosis
9) Decompensated heart failure
10) Drug or alcohol dependence
11) Unstable mental disease
12) Malignant tumor
13) Comorbidity affecting primary outcome
14) Inappropriate for inclusion in the study

Study & Design

• Study Type: Interventional
• Study Design: Not specified